Targeting MERTK and AXL in EGFR Mutant Non-Small Cell Lung Cancer

SIMPLE SUMMARY: Expression of MERTK and/or AXL (members of the TAM family of receptor tyrosine kinases) provides a survival advantage for non-small cell lung cancer (NSCLC) cells and correlates with lymph node metastasis, drug resistance, and disease progression. TAM receptors on host tumor infiltra...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Dan, Earp, H. Shelton, DeRyckere, Deborah, Graham, Douglas K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616094/
https://www.ncbi.nlm.nih.gov/pubmed/34830794
http://dx.doi.org/10.3390/cancers13225639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616094/
https://www.ncbi.nlm.nih.gov/pubmed/34830794
http://dx.doi.org/10.3390/cancers13225639

Ejemplares similares